RadNet

breast cancer mammogram
MedTech

RadNet to absorb mammography AI developer iCad in $103M deal

The all-stock transaction is valued at about $103 million, or a 98% premium over iCad’s recent share price.
Conor Hale Apr 16, 2025 2:05pm
GE Healthcare Building

GE HealthCare inks collab with RadNet in mammography AI

Nov 12, 2024 10:10am
artificial intelligence chip

RadNet scores FDA clearances for AI in breast, prostate cancers

May 16, 2022 11:31am